ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Structure Therapeutics
Structure Therapeutics is seeking a Principal Scientist to Director level in Structural Biology to contribute to drug discovery projects involving structural analysis of drug targets. The role focuses on understanding the fundamental mechanisms of drug targets using advanced cryo-electron microscopy and X-ray crystallography techniques.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
Structure Therapeutics didn’t post a salary, so this is our estimate from similar listings.
13% above the average for this role
Research Scientist
University of Washington Intercollegiate Athletics
Research Associate
Jefferson, Thomas University Hospitals Systems
Head of Biochemistry and Structural Biology
wattonhall
Postdoctoral Research Associate in Membrane Protein Structural Biology
Iowa State University
Research Scientist - GPCR Pharmacology and Structural Biology
University of North Carolina System
Join a European Doctoral Network to Reveal New Principles of Kinase Regulation
VIB Vermögen AG